We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Unsedated Transnasal Endoscopy Safe and Feasible

By HospiMedica International staff writers
Posted on 18 Jun 2012
A new study reports that unsedated transnasal endoscopy (TNE) is a feasible, safe, and well-tolerated method to screen for esophageal disease in a primary care population. More...


Researchers at the University of Pittsburgh Medical Center (UPMC; PA, USA) and the University of North Carolina (Chapel Hill, USA) conducted a multicenter, prospective, cross-sectional study involving 426 participants (aged 40-85 years) to assess the feasibility, safety, acceptability, and yield of unsedated TNE. Main outcome measures included procedure yield, completeness of examination, procedure length, adverse events and complications, and overall tolerability.

The results showed that mean examination time was 3.7 minutes. There were no serious adverse events, and only 12 participants reported minor complications. The examination was well tolerated by most participants, who reported minimal choking, gagging, pain, or anxiety. Overall, 38% of participants had an esophageal finding that changed management (34% erosive esophagitis, 4% Barrett's esophagus), with the majority reported reflux or heartburn symptoms. The study was published in the May 2012 issue of Gastrointestinal Endoscopy.

“Unsedated transnasal endoscopy is both feasible and safe in a primary care population, achieving short procedure times, a high diagnostic yield, and minimal anxiety,” concluded study coauthor Blair Jobe, MD, of UPMC, and colleagues. “Patients reported good acceptability and minimal discomfort. These results suggest that we can now lower the threshold for endoscopic esophageal screening and with less cost.”

TNE uses ultrathin endoscopes that are passed through the patient's nose into the esophagus for performance of an upper endoscopy; typically, the examination is carried out at least to the level of the proximal-to-mid stomach, depending on the height of the patient. Often, TNE can be performed without sedation through the use of topical anesthetics sprayed into the patient's nose and/or mouth. Avoiding intravenous sedation allows patients to drive following the examination, and eliminates the need for a second person to accompany the patient.

Related Links:

University of Pittsburgh Medical Center
University of North Carolina



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.